Lymphopenia in treatment-naive relapsing multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 20, 2015
- Accepted in final form July 11, 2016
- First Published August 12, 2016.
Author Disclosures
- Zhi Wei Lim, BM BS,
- Elliot Elwood, BM BS,
- Hammad Naveed, MSc and
- Ian Galea, PhD
- Zhi Wei Lim, BM BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elliot Elwood, BM BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hammad Naveed, MSc and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ian Galea, PhD
NONE
NONE
Teva-UK (meeting expenses)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Evgen, Merck Serono, Spire
Engineering and Physical Sciences Research Council UK, Medical Research Council UK
Wessex Medical Research, NIHR Clinical Research Network Wessex, Royal College of Surgeons of Edinburgh, University of Southampton
MS Society, Association of British Neurologists, Smile4Wessex
NONE
NONE
NONE
NONE
NONE
NONE
- From Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
- Correspondence to Dr. Galea: I.Galea{at}soton.ac.uk
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Research
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MSPatient management considerationsRobert J. Fox, Andrew Chan, Ralf Gold et al.Neurology: Clinical Practice, April 01, 2016 -
Research
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MSAndrew Chan, John Rose, Enrique Alvarez et al.Neurology: Clinical Practice, January 02, 2020 -
Review
Lymphopenia and DMTs for relapsing forms of MSConsiderations for the treating neurologistEdward J. Fox, Guy J. Buckle, Barry Singer et al.Neurology: Clinical Practice, January 08, 2019 -
Article
Effect of dimethyl fumarate on lymphocytes in RRMSImplications for clinical practiceDevangi Mehta, Catherine Miller, Douglas L. Arnold et al.Neurology, March 27, 2019